Close Menu

NEW YORK (GenomeWeb) – Mobidiag, a Finnish molecular diagnostics maker, has entered an agreement with Chinese clinical diagnostics firm Autobio Diagnostics to establish a joint venture in China. Separately, Autobio Diagnostics has made a €10 million ($11.3 million) equity investment in Mobidiag, the firms announced today.

Mobidiag and Autobio will invest a total of €12.3 million to establish the joint venture company, with Autobio investing €8 million in the JV for a 65 percent stake, and Mobidiag investing €4.3 million for a 35 percent stake. 

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Feb
23
Sponsored by
Thermo Fisher Scientific

As the world continues to contend with coronavirus and a surge in the infection rate, labs are required to run more samples than ever before. 

Feb
24
Sponsored by
SCHOTT MINIFAB

Developing a fully integrated consumable cartridge for an automated diagnostic platform is a significant challenge. More challenging still is developing such a cartridge in response to a deadly global virus pandemic amid market uncertainty and extraordinary time constraints.